Invited Speakers & Chairs

Bertil  Abrahamsson AstraZeneca Sweden
Andrea  Adamo MIT USA
Murray Aitken QuintilesIMS Institute USA
Ahmed Ali RIKEN Quantitative Biology Center Japan
Thomas Allvin EFPIA Sweden
Maria José Alonso University of Santiago de Compostela Spain
Zane Arp GSK Bioimaging USA
Per Artursson University of Uppsala Sweden
Charlie  Benrimoj University of Technology Sydney Australia
Christel  Bergström Uppsala University Sweden
Mark Bolgar Bristol-Myers Squibb USA
Gerrit  Borchard  University of Geneva Switzerland
David  Brayden University College Dublin Ireland
Alasdair  Breckenridge University of Liverpool UK
Jurgen Brem University of Oxford UK
Douwe Breimer LACDR, Leiden University The Netherlands
Kathryn Browning Uppsala University Sweden
Rebecca Carrier Northeastern University USA
Alison Cave European Medicines Agency UK
Arnold  Chan National Taiwan University China Taiwan
Timothy  Chen University of Sydney Australia
Magda Chlebus European Federation of Pharmaceutical Industries and Associations Belgium
Daan Crommelin Utrecht University The Netherlands
Rebecca  Davies University of Minnesota USA
Marieke  De Bruin University of Copenhagen Denmark
Oleg  Demin ISB Moscow Russian Federation
Ron  De Winter COMBACTE The Netherlands
Sara Eapen Aetion Inc. USA
Andrea Edginton  University of Waterloo Canada
Falk  Ehmann EMA   UK
Hans-Georg  Eichler European Medicines. Agency UK
William Evans St Jude's Children Research Hospital USA
Alan  Fairlamb University of Dundee UK
Fernando  Fernandez-Llimos University of Lisbon Portugal
Staffan  Folestad AstraZeneca Sweden
Rogerio Gaspar  University of Lisbon Portugal
Kathy  Giacomini University of California USA
David  Gonsalvez Malaysia Institute for Supply Chain Innovation (MISI) Malaysia
Alvaro  Goyanes UCL UK
Jeremie Guedj INSERM France
Linda Hakes FIP UK
Thomas Hankemeier Leiden Academic Centre for Drug Research The Netherlands
Sifei Han Monash University Australia
Mike  Hann GlaxoSmithKline UK
Tomás S. Harrington University of Cambridge UK
Dan Hartman Bill & Melinda Gates Foundation USA
Jens  Heisterberg Novo Nordisk Denmark
Rob  Hemmings  EMA/MHRA UK
Brian  Henry Pfizer Worldwide Research and Development UK
Susan  Hershenson  Bill & Melinda Gates Foundation USA
Akihiko  Hirose National Institute of Health Sciences Japan
Iain  Hrynaszkiewicz HSS Publishing, Open Research, Nature/Springer UK
David  Jackson Molecular Health Germany
Vincent  Jannin Gattefossé, France France
Ulf Janzon Merck Sweden
Craig  Johnston University of Strathclyde UK
Anders  Karlén Univsersity of Uppsala Sweden
Kataoka Kazunori  University of Tokyo Japan
Steven Kern Bill & Melinda Gates Foundation USA
Hiroaki Kitano Systems Biology Inistitute Japan
Catherijne  Knibbe St Antonius Ziekenhuis & Leiden University The Netherlands
Atanas  Koulov Lonza Switzerland
Michaki  Kubo RIKEN, Japan  Japan
Takuya  Kumamoto Musashino University Japan
Twan Lammers RWTH Aachen University Clinic Germany
Hans  Lennernäs Uppsala University Sweden
Bert Leufkens Utrecht University The Netherlands
Larry Liberti Centre for Innovation in Regulatory Science (CIRS) USA
Beatriz Lima University of Lisbon Portugal
Murray  Lumpkin Bill & Melinda Gates Foundation USA
Don  Mager University at Buffalo USA
Hanns-Christian  Mahler Lonza Switzerland
Tsutomu  Masujima RIKEN Quantitative Biology Center Japan
André  Mateus   University of Uppsala Sweden
Ross  McKinnon Flinders University  Australia
Scott  McNeil National Cancer Institute USA
Jay  Mettetal AstraZeneca USA
Pierre Meulien Innovative Medicines Initiative Belgium
Ding  Ming USP USA
Barend  Mons  Leiden University Medical Center The Netherlands
Marilyn  Morris University at Buffalo USA
Randy  Mrsny  University of Bath UK
Stefan  Mühlebach University of Basel Switzerland
Willem Mulder Mount Sinai School of Medicine USA
Adam Nelson Leeds University UK
Mikko  Niemi University of Helsinki Finland
Olatunde James Olaitan University of Lagos Nigeria
Tudor Oprea University of New Mexico USA
Giovanni  Pauletti ‎University of Cincinnati, Winkle College of Pharmacy USA
Chad Pickens The University of Kansas USA
Carl  Peck UCSF USA
Dan Peer Tel Aviv University Israel
Munir Pirmohamed University of Liverpool UK
Christopher  Porter Monash University Australia
Tim  Radstake University Medical Center Utrecht The Netherlands
Paulina Rakowska National Physical Laboratory UK
Jukka Rantanen University of Copenhagen Denmark
Mary  Relling St. Jude’s Children’s Research Hospital USA
Ton Rijnders Lygature The Netherlands
Klaus Romero The Critical Path Institute USA
Amin  Rostami-Hodjegan University of Manchester UK
Anna Rutkowska-Klute Cellzome Germany
Tomas Salmonson Medical Products Agency  Sweden
Niklas  Sandler Åbo Akademi University Finland
Ferran  Sanz Pompeu Fabra University Spain
Masanobu Sato Pharmaceuticals and Medical Devices Agency  Japan
Rada  Savic University of California USA
Joseph  Scheeren Bayer Switzerland
Jan  Schellens Netherlands Cancer Institute The Netherlands
Jean-Michel Scherrmann Paris Descartes University France
Martin  Schulz Freie Universitat Berlin Germany
Anton  Simeonov National Institutes of Health USA
Thomas Steckler Janssen R&D Belgium
Paul Song Samsung Bioepis Korea
Yuichi Sugiyama  University of Tokyo Japan
Michael Sundstrom Karolinska Institute Sweden
Hiroshi Suzuki University of Tokyo Japan
Jesse  Swen Leiden University Medical Center The Netherlands
Toshiyoshi  Tominaga  PMDA Japan
Istvan Toth The University of Queensland Australia
Mirjam Trame University of Florida USA
Ross  Tsuyuki University of Alberta Canada
Dimitrios  Tzalis Taros Chemicals Germany
Mathias Uhlen Royal Institute of Technology Sweden
Piet  van der Graaf Leiden University The Netherlands
Ron  van Schaik Erasmus Medical Center The Netherlands
Paolo  Vicini MedImmune UK
Paul  Wan Sia Heng National University of Singapore Singapore
Peter Warner Bill & Melinda Gates Foundation USA
Almut  Winterstein University of Florida USA
Songlin  Xue Astellas USA
Shinji  Yamashita Setsunan University Japan
Zhiyuan  Zhong Soochow University  China